Global Health Headlines: Major Developments in Medications and Outbreaks

Recent health news includes a court ruling allowing Amgen's Eylea biosimilar launch, Starboard criticizing Kenvue's skin health segment, a bacterial outbreak causing monkey deaths in Hong Kong, E. coli linked to McDonald's, rapid medical delivery by Walmart, Germany's new mpox detection, and restrictions on Eli Lilly's Alzheimer's drug in the UK.

In a significant legal decision, Amgen has been given the green light to launch a biosimilar version of Regeneron's eye care drug, Eylea, after the U.S. Court of Appeals sided with Amgen in a patent dispute.

Meanwhile, Starboard Value criticized Kenvue's skin health segment for its weak performance, urging action to boost its revenue growth. The hedge fund highlighted opportunities for improving margins at Kenvue, which owns popular brands like Neutrogena and Aveeno.

A worrying outbreak of Melioidosis in Hong Kong resulted in the death of a twelfth monkey this week, with concerns over its potential spread to humans. Elsewhere, Walmart is upping its delivery game, now offering prescriptions within 30 minutes, challenging Amazon's recent pharmacy initiatives.

(With inputs from agencies.)